Kaixuan Li1, Meihong Yu2,3, Haozhen Li1, Quan Zhu1, Ziqiang Wu1, Zhao Wang1,4, Zhengyan Tang1,5. 1. Department of Urology, Xiangya Hospital of Central South University, Changsha, 410008, People's Republic of China. 2. Department of Gastroenterology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, People's Republic of China. 3. Research Center of Digestive Disease, Central South University, Changsha, Hunan, 410011, People's Republic of China. 4. National Clinical Research Center for Geriatric Disorders, Changsha, 410008, People's Republic of China. 5. Provincial Laboratory for Diagnosis and Treatment of Genitourinary System Disease, Changsha, 410000, People's Republic of China.
Abstract
Purpose: Venous thromboembolism (VTE) comprises deep venous thrombosis (DVT) and pulmonary embolism (PE), which can lead to death. VTE is an insidious disease with no specific symptoms and overlooked readily. We aimed to establish prediction models for VTE in non-oncological urological inpatients to aid urologists to better identify VTE patients. Patients and Methods: A retrospective analysis of 1453 inpatients was carried out. The risk factors for VTE had been clarified in our previous study. A stepwise regression method was used to screen the relevant influencing factors for VTE and construct a logistic regression prediction model to predict VTE. To validate the accuracy of the model, data from 291 patients from another cohort were used for external validation. Results: A total of 1453 inpatients were enrolled. Five potential risk factors (previous VTE; treatment with anticoagulants or anti-platelet agents before hospital admission; D-dimer ≥0.89 μg/mL; lower-extremity swelling; chest symptoms) were selected by multivariable analysis with p < 0.05. These five risk factors were used to build a logistic regression prediction model. When p < 0.1 in the multivariable logistic regression model, two additional risk factors were added: Caprini score ≥5 and complications, and all seven risk factors were used to build another prediction model. Internal verification showed the cutoff values, sensitivity, and specificity of the two models to be 0.02474, 0.941, 0.816 (model 1) and 0.03824, 0.941, and 0.820 (model 2), respectively. Both models had good predictive ability, but prediction accuracy was 43.0% for both when using the data of the additional 291 inpatients in the two models. Conclusion: Two novel prediction models were built to predict VTE in non-oncological urological inpatients. This is a new method for VTE screening, and internal validation showed a good performance. External validation results were suboptimal but may provide clues for subsequent VTE screening.
Purpose: Venous thromboembolism (VTE) comprises deep venous thrombosis (DVT) and pulmonary embolism (PE), which can lead to death. VTE is an insidious disease with no specific symptoms and overlooked readily. We aimed to establish prediction models for VTE in non-oncological urological inpatients to aid urologists to better identify VTE patients. Patients and Methods: A retrospective analysis of 1453 inpatients was carried out. The risk factors for VTE had been clarified in our previous study. A stepwise regression method was used to screen the relevant influencing factors for VTE and construct a logistic regression prediction model to predict VTE. To validate the accuracy of the model, data from 291 patients from another cohort were used for external validation. Results: A total of 1453 inpatients were enrolled. Five potential risk factors (previous VTE; treatment with anticoagulants or anti-platelet agents before hospital admission; D-dimer ≥0.89 μg/mL; lower-extremity swelling; chest symptoms) were selected by multivariable analysis with p < 0.05. These five risk factors were used to build a logistic regression prediction model. When p < 0.1 in the multivariable logistic regression model, two additional risk factors were added: Caprini score ≥5 and complications, and all seven risk factors were used to build another prediction model. Internal verification showed the cutoff values, sensitivity, and specificity of the two models to be 0.02474, 0.941, 0.816 (model 1) and 0.03824, 0.941, and 0.820 (model 2), respectively. Both models had good predictive ability, but prediction accuracy was 43.0% for both when using the data of the additional 291 inpatients in the two models. Conclusion: Two novel prediction models were built to predict VTE in non-oncological urological inpatients. This is a new method for VTE screening, and internal validation showed a good performance. External validation results were suboptimal but may provide clues for subsequent VTE screening.
Authors: Philippe D Violette; Luke T Lavallée; Wassim Kassouf; Peter L Gross; Bobby Shayegan Journal: Can Urol Assoc J Date: 2018-12-14 Impact factor: 1.862
Authors: Krista J Hachey; Philip D Hewes; Liam P Porter; Douglas G Ridyard; Pamela Rosenkranz; David McAneny; Hiran C Fernando; Virginia R Litle Journal: J Thorac Cardiovasc Surg Date: 2015-08-15 Impact factor: 5.209
Authors: Kari A O Tikkinen; Samantha Craigie; Arnav Agarwal; Reed A C Siemieniuk; Rufus Cartwright; Philippe D Violette; Giacomo Novara; Richard Naspro; Chika Agbassi; Bassel Ali; Maha Imam; Nofisat Ismaila; Denise Kam; Michael K Gould; Per Morten Sandset; Gordon H Guyatt Journal: Eur Urol Date: 2017-03-09 Impact factor: 20.096
Authors: Angelika Bezan; Florian Posch; Ferdinand Ploner; Thomas Bauernhofer; Martin Pichler; Joanna Szkandera; Georg C Hutterer; Karl Pummer; Thomas Gary; Hellmut Samonigg; Joerg Beyer; Thomas Winder; Thomas Hermanns; Christian D Fankhauser; Armin Gerger; Michael Stotz Journal: PLoS One Date: 2017-04-21 Impact factor: 3.240